372 related articles for article (PubMed ID: 22285656)
1. α7 neuronal nicotinic receptor agonist (TC-7020) reverses increased striatal dopamine release during acoustic PPI testing in a transgenic mouse model of schizophrenia.
Kucinski A; Syposs C; Wersinger S; Bencherif M; Stachowiak MK; Stachowiak EK
Schizophr Res; 2012 Apr; 136(1-3):82-7. PubMed ID: 22285656
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor receptor signaling affects development and function of dopamine neurons - inhibition results in a schizophrenia-like syndrome in transgenic mice.
Klejbor I; Myers JM; Hausknecht K; Corso TD; Gambino AS; Morys J; Maher PA; Hard R; Richards J; Stachowiak EK; Stachowiak MK
J Neurochem; 2006 Jun; 97(5):1243-58. PubMed ID: 16524369
[TBL] [Abstract][Full Text] [Related]
3. The effects of varenicline on sensory gating and exploratory behavior with pretreatment with nicotinic or 5-HT3A receptor antagonists.
Kucinski A; Wersinger S; Stachowiak EK; Becker C; Lippiello P; Bencherif M; Stachowiak MK
Behav Pharmacol; 2015 Feb; 26(1-2):217-26. PubMed ID: 25485645
[TBL] [Abstract][Full Text] [Related]
4. TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia.
Hauser TA; Kucinski A; Jordan KG; Gatto GJ; Wersinger SR; Hesse RA; Stachowiak EK; Stachowiak MK; Papke RL; Lippiello PM; Bencherif M
Biochem Pharmacol; 2009 Oct; 78(7):803-12. PubMed ID: 19482012
[TBL] [Abstract][Full Text] [Related]
5. Possible role of the dopamine D1 receptor in the sensorimotor gating deficits induced by high-fat diet.
Wakabayashi C; Numakawa T; Ooshima Y; Hattori K; Kunugi H
Psychopharmacology (Berl); 2015 Dec; 232(24):4393-400. PubMed ID: 26359228
[TBL] [Abstract][Full Text] [Related]
6. Acoustic startle response, prepulse inhibition, and spontaneous locomotor activity in MPTP-treated mice.
Leng A; Yee BK; Feldon J; Ferger B
Behav Brain Res; 2004 Oct; 154(2):449-56. PubMed ID: 15313033
[TBL] [Abstract][Full Text] [Related]
7. The role of ephrin-A2 and ephrin-A5 in sensorimotor control and gating.
Yates NJ; Martin-Iverson MT; Rodger J
Behav Brain Res; 2014 Dec; 275():225-33. PubMed ID: 25200515
[TBL] [Abstract][Full Text] [Related]
8. Neuronal nicotinic receptor agonists ameliorate spontaneous motor asymmetries and motor discoordination in a unilateral mouse model of Parkinson's disease.
Kucinski A; Wersinger S; Stachowiak EK; Corso TD; Parry MJ; Zhang J; Jordan K; Letchworth S; Bencherif M; Stachowiak MK
Pharmacol Biochem Behav; 2013 Oct; 111():1-10. PubMed ID: 23872135
[TBL] [Abstract][Full Text] [Related]
9. Dorsal striatum D1-expressing neurons are involved with sensorimotor gating on prepulse inhibition test.
Rodrigues S; Salum C; Ferreira TL
J Psychopharmacol; 2017 Apr; 31(4):505-513. PubMed ID: 28114835
[TBL] [Abstract][Full Text] [Related]
10. Sensorimotor gating in neurotensin-1 receptor null mice.
Feifel D; Pang Z; Shilling PD; Melendez G; Schreiber R; Button D
Neuropharmacology; 2010 Jan; 58(1):173-8. PubMed ID: 19596359
[TBL] [Abstract][Full Text] [Related]
11. Relationship between sensorimotor gating deficits and dopaminergic neuroanatomy in Nurr1-deficient mice.
Vuillermot S; Feldon J; Meyer U
Exp Neurol; 2011 Nov; 232(1):22-32. PubMed ID: 21820432
[TBL] [Abstract][Full Text] [Related]
12. Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia.
Lipina TV; Niwa M; Jaaro-Peled H; Fletcher PJ; Seeman P; Sawa A; Roder JC
Genes Brain Behav; 2010 Oct; 9(7):777-89. PubMed ID: 20618446
[TBL] [Abstract][Full Text] [Related]
13. Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice.
Caldwell HK; Stephens SL; Young WS
Mol Psychiatry; 2009 Feb; 14(2):190-6. PubMed ID: 18227836
[TBL] [Abstract][Full Text] [Related]
14. Disruption of the prepulse inhibition of the startle reflex in vasopressin V1b receptor knockout mice: reversal by antipsychotic drugs.
Egashira N; Tanoue A; Higashihara F; Fuchigami H; Sano K; Mishima K; Fukue Y; Nagai H; Takano Y; Tsujimoto G; Stemmelin J; Griebel G; Iwasaki K; Ikeda T; Nishimura R; Fujiwara M
Neuropsychopharmacology; 2005 Nov; 30(11):1996-2005. PubMed ID: 15956991
[TBL] [Abstract][Full Text] [Related]
15. Striatal dopamine receptor plasticity in neurotensin deficient mice.
Chastain LG; Qu H; Bourke CH; Iuvone PM; Dobner PR; Nemeroff CB; Kinkead B
Behav Brain Res; 2015 Mar; 280():160-71. PubMed ID: 25449842
[TBL] [Abstract][Full Text] [Related]
16. Selective alpha7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes.
Sydserff S; Sutton EJ; Song D; Quirk MC; Maciag C; Li C; Jonak G; Gurley D; Gordon JC; Christian EP; Doherty JJ; Hudzik T; Johnson E; Mrzljak L; Piser T; Smagin GN; Wang Y; Widzowski D; Smith JS
Biochem Pharmacol; 2009 Oct; 78(7):880-8. PubMed ID: 19615981
[TBL] [Abstract][Full Text] [Related]
17. Histamine H3 Receptor Regulates Sensorimotor Gating and Dopaminergic Signaling in the Striatum.
Kononoff Vanhanen J; Nuutinen S; Tuominen M; Panula P
J Pharmacol Exp Ther; 2016 May; 357(2):264-72. PubMed ID: 26945087
[TBL] [Abstract][Full Text] [Related]
18. Forebrain D1 function and sensorimotor gating in rats: effects of D1 blockade, frontal lesions and dopamine denervation.
Swerdlow NR; Shoemaker JM; Kuczenski R; Bongiovanni MJ; Neary AC; Tochen LS; Saint Marie RL
Neurosci Lett; 2006 Jul; 402(1-2):40-5. PubMed ID: 16644125
[TBL] [Abstract][Full Text] [Related]
19. Neural monoaminergic mediation of the effect of St. John's wort extract on prepulse inhibition of the acoustic startle response in rats.
Khalifa AE
J Psychopharmacol; 2005 Sep; 19(5):467-72. PubMed ID: 16166183
[TBL] [Abstract][Full Text] [Related]
20. Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats.
Callahan PM; Terry AV; Tehim A
Psychopharmacology (Berl); 2014 Sep; 231(18):3695-706. PubMed ID: 24595504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
